Ischemia Cli Product Applications

2 applications found

Potential breakthrough treatment option for Critical Limb Ischemia (CLI)

Our First DCGI Approved Stem Cell Product: Stempeucel® is the FIRST innovative stem cell based biological product to be approved by DCGI (Indian FDA) for manufacturing and marketing for the treatment of Critical Limb Ischemia (CLI). Stempeucel® product has been licensed to Cipla in India. ...

ByStempeutics Research Pvt. Ltd. based in Bangalore, INDIA

Balloon Catheter for Peripheral Arterial Disease

Peripheral Arterial Disease (PAD) is a growing public health issue affecting 202 million people worldwide.1 It is an obstruction of the blood flow in the peripheral arteries, most commonly to the lower limbs and ...

ByQT Vascular Ltd. based in , SINGAPORE

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you